Notify me when PATRICK G. ENRIGHT files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Common Stock, $0.0001 par value per share | 6% | $121,032,477 | 4,662,268 | Patrick G. Enright | 11 Sep 2025 | ||
| ZBIO | ZENAS BIOPHARMA, INC. | Common Stock, $0.0001 par value per share | 4.9% | $58,425,578 | 2,631,522 | Patrick G. Enright | 09 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|